menu
    • menu

    Looking for Polysorbate 80 pharmaceutical excipients? Find information on Polysorbate 80's applications, manufacturers, suppliers, etc. on PharmaCompass.

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set

    SUPPLIERS

    read-more
    read-more
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    CEP/COS

    read-more
    read-moreread-more

    NANJING WELL PHARMACEUTICAL GROUP C...

    Contact Supplier
      • fda
      • EDQM
      • WHO-GMP

      Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

      Contact Supplier Contact Supplier
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Polysorbate 80

      Portfolio PDF

      Product Web Link

      Virtual Booth

      Digital Content

      Website

      Corporate PDF

      R0-CEP 2020-419 - Rev 00
      Valid
      Chemical
      2022-04-01
      428
      Nanjing Well Pharmaceutical

      01

      NANJING WELL PHARMACEUTICAL GROUP C...

      China
      arrow
      IPPE
      Not Confirmed
      • fda
      • EDQM
      • WHO-GMP

      Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

      Contact Supplier Contact Supplier
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Polysorbate 80

      Certificate Number : R0-CEP 2020-419 - Rev 00

      Status : Valid

      Issue Date : 2022-04-01

      Type : Chemical

      Substance Number : 428

      Nanjing Well Pharmaceutical

      Portfolio PDF

      Product Web Link

      Virtual Booth

      Digital Content

      Website

      Corporate PDF

      KOLB DISTRIBUTION LTD. Hedingen CH

      Contact Supplier
        • fda
        • EDQM
        • WHO-GMP
        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
        Post an Enquiry Post an Enquiry
        Flag Switzerland
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Polysorbate 80

        Portfolio PDF

        Product Web Link

        Virtual Booth

        Digital Content

        Website

        Corporate PDF

        R0-CEP 2020-048 - Rev 00
        Withdrawn by Holder
        Chemical
        2020-09-04
        2025-08-12
        428
        blank

        02

        KOLB DISTRIBUTION LTD. Hedingen CH

        Switzerland
        IPPE
        Not Confirmed
        arrow

        KOLB DISTRIBUTION LTD. Hedingen CH

        Switzerland
        arrow
        IPPE
        Not Confirmed
        • fda
        • EDQM
        • WHO-GMP
        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
        Post an Enquiry Post an Enquiry
        Flag Switzerland
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Polysorbate 80

        Certificate Number : R0-CEP 2020-048 - Rev 00

        Status : Withdrawn by Holder

        Issue Date : 2020-09-04

        Type : Chemical

        Substance Number : 428

        blank

        Portfolio PDF

        Product Web Link

        Virtual Booth

        Digital Content

        Website

        Corporate PDF

        SEPPIC S.A. Paris Cedex 07 FR

        Contact Supplier
        • EDQM
        • fda
        • EDQM
        • WHO-GMP
        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
        Post an Enquiry Post an Enquiry
        Flag France
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Polysorbate 80, Montanox 80 DF RPR D Montanox 80 DF PPI

        Portfolio PDF

        Product Web Link

        Virtual Booth

        Digital Content

        Website

        Corporate PDF

        R0-CEP 2000-310 - Rev 02
        Withdrawn by Holder
        TSE
        2005-03-16
        2006-08-04
        428
        blank

        03

        SEPPIC S.A. Paris Cedex 07 FR

        France
        IPPE
        Not Confirmed
        arrow
        Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

        FINISHED DOSAGE FORMULATIONS

        Upload your portfolio for free, ask us

        EXCIPIENTS BY APPLICATIONS

        Click here to find the perfect excipient manufacturers by their capabilities

        Solubilizers

        read-more
        read-more

        Parenteral

        read-more
        read-more

        01

        Nanjing Well Pharmaceutical

        China
        arrow
        IPPE
        Not Confirmed
        • fda
        • EDQM
        • WHO-GMP

        Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

        Dosage Form : Injectable / Parenteral

        Grade : Parenteral, Oral, Topical

        Category : Parenteral

        Brand Name : Polysorbate 80

        Application : Parenteral

        Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.

        Pharmacopoeia Ref : ChP/USP/EP/JP

        Technical Specs : NA

        Ingredient(s) : Polysorbate 80

        arrow
        Polysorbate 80

        Excipients Web Link

        Virtual Booth

        02

        Kirsch Pharma

        Germany
        arrow
        IPPE
        Not Confirmed
        • fda
        • EDQM
        • WHO-GMP

        Virtual BoothHigh-quality raw materials and custom blends for pharma, biopharma, nutrition, veterinary, and cosmetics worldwide.

        Dosage Form : Injectable / Parenteral

        Grade : Biopharma Grade

        Category : Parenteral

        Brand Name : Tween 80

        Application : Parenteral

        Excipient Details : Used as surfactant agent in cell culture media, in protein purification and in injectable formulations.

        Pharmacopoeia Ref : On Request

        Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...

        Ingredient(s) : Polysorbate 80

        arrow
        TWEEN 80

        Excipients Web Link

        Virtual Booth

        03

        Seppic

        France
        IPPE
        Not Confirmed
        arrow

        04

        Seppic

        France
        IPPE
        Not Confirmed
        arrow

        05

        Seppic

        France
        IPPE
        Not Confirmed
        arrow

        06

        Seppic

        France
        IPPE
        Not Confirmed
        arrow

        Topical

        read-more
        read-more

        Surfactant Foaming Agents

        read-more
        read-more

        Emulsifying Agents

        read-more
        read-more

        Thickeners And Stabilizers

        read-more
        read-more

        Film Formers Plasticizers

        read-more
        read-more

        Co Processed Excipients

        read-more
        read-more

        Direct Compression

        read-more
        read-more

        01

        Seppic

        France
        IPPE
        Not Confirmed
        arrow

        02

        Gangwal Chemicals

        India
        IPPE
        Not Confirmed
        arrow

        Rheology Modifiers

        read-more
        read-more

        API Stability Enhancers

        read-more
        read-more

        Digital Content read-more

        Create Content with PharmaCompass, ask us

        DATA COMPILATION #PharmaFlow

        read-more
        read-more
        Excipient Market Overview: Roquette, Seqens, Evonik make strategic moves; new guidelines deal with contamination

        Excipient Market Overview: Roquette, Seqens, Evonik make strategic moves; new guidelines deal with contamination

        The pharmaceutical industry has long recognized the critical role excipients or inactive ingredients play in drug formulation and delivery. Excipients can comprise up to 90 percent of a medicine's total ingredients and serve crucial functions as binders, disintegrants, coatings, preservatives, colors, and flavorings. According to recent market research, the pharmaceutical excipients market was valued at US$ 9.27 billion in 2023. It is growing at a compound annual growth rate (CAGR) of 7.03 percent and is projected to reach US$ 18.48 billion by 2032. The main factors driving market growth is an increased demand for multifunctional excipients, coupled with the expanding use of generic medications. The development in the biologics sector and advancements in nanotechnology are also contributing significantly to market growth. Major excipient providers include BASF, Evonik, Merck KGaA owned MilliporeSigma, Gangwal Healthcare, Roquette Frères, DuPont, Croda International, Seqens, Boai NKY Pharmaceuticals, PMC Isochem, Minakem, Kewpie Corporation, Ashland Global, SPI Pharma, Pfanstiehl, Nanjing Well Pharmaceutical, ICE Pharma, Anhui Ribobay Pharmaceutical and Nippon Fine Chemical.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available) WHO, India’s CDSCO tighten regulations; new GMP guidelines implemented to curb contamination Last year, the World Health Organization (WHO) issued a health alert linking at least 300 child deaths in the Gambia, Uzbekistan, and Indonesia to the ingestion of contaminated cough syrups containing unacceptable levels of diethylene glycol (DEG) and ethylene glycol (EG). In response to the tragic events, the WHO released two draft appendices to its guideline on good manufacturing practices (GMPs) for excipients this year. Manufacturers are now required to use suitable risk assessment tools to identify and mitigate potential hazards.  Since India-made cough syrups had been linked to the deaths, India’s drug regulator — Central Drugs Standard Control Organization (CDSCO) — took steps to prevent contamination, and advised drugmakers to only use pharmaceutical-grade excipients from approved sources. Furthermore, the Indian Health Ministry proposed amendments to the Drugs and Cosmetics Rules, 1945 to include details of excipients on drug labels. While listing all excipients on every strip of medicine may be challenging, the ministry suggested mentioning those causing hypersensitivity on the label. Applicants now mandatorily need to submit evidence of stability and safety of excipients. These regulatory developments have significant implications for excipient manufacturers and pharmaceutical companies worldwide. Leading pharmaceutical excipient firms like Gangwal Healthcare, Sigachi Industries, and Nitika Pharmaceuticals are well-positioned to meet these heightened quality and safety standards, given their long-standing commitment to producing high-quality, compliant excipients.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Roquette buys IFF’s pharma unit for US$ 2.85 bn; Evonik opens new spray-drying facility in Darmstadt In a significant industry move, France-based Roquette entered into an agreement to acquire IFF's pharma solutions business in a deal valued at US$ 2.85 billion. This acquisition is set to rebalance family-owned Roquette’s portfolio around health and nutrition. The deal is expected to accelerate Roquette’s growth and significantly strengthen its presence in the excipients market. Evonik has opened a new facility for drying aqueous dispersions of its Eudragit polymers at its site in Darmstadt, Germany. The facility will help Evonik meet increasing demand from drugmakers for its oral drug delivery solutions. The plant uses green energy solutions. The company has also partnered University of Mainz to commercialize a new class of polyethylene glycols (PEG) lipids for nucleic acid delivery. Evonik’s Health Care business has been growing its nucleic acid drug and vaccine delivery portfolio.  Germany’s Johannes Gutenberg University of Mainz was the first to develop randomized polyethylene glycols (rPEGs). This collaboration aims to expand Evonik’s toolbox of technologies for nucleic acid-based medicines, offering an improved immunogenicity profile for lipid nanoparticle carriers used in mRNA vaccines and therapeutics. Asahi Kasei made significant strides in addressing a pressing industry concern that emerged in 2018 when potentially carcinogenic nitrosamine impurities were detected in several pharmaceuticals. Guided by regional authorities, such as the European Medicines Agency and the US Food and Drug Administration, the pharmaceutical industry has been carrying out extensive assessments and research to identify the cause of these impurities. In response to this challenge, Asahi Kasei developed its Ceolus microcrystalline cellulose with extremely low nitrite levels. The Japanese company achieved nitrite concentrations of 0.1 micrograms per gram or less, which is equivalent to 0.1 parts per million (ppm). The company also started full commercial operation of its second manufacturing facility for Ceolus in Japan, enhancing supply capacity and stability. JRS Pharma and Gujarat Microwax opened a state-of-the-art cotton-based croscarmellose sodium plant in Mehsana, Gujarat (India). This facility aims to produce high-quality excipients that meet global standards, potentially reducing India's dependency on imports and boosting its presence in the global excipient market. The Indian excipient industry accounts for less than 1 percent of the global market share.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Seqens to advance innovative polymer; biologics, personalized medicine create demand for specialized excipients Recent industry collaborations highlight the ongoing innovation in novel excipients. France’s Seqens, with over 20 years of polymer development experience, was chosen by Pleryon Therapeutics to advance its leading osteoarthritis candidate – an innovative GMP polymer. This collaboration leverages Seqens’ newly expanded and modernized cGMP plant in Aramon, France, demonstrating the industry’s commitment to investing in advanced manufacturing capabilities for novel excipients.  The rise of biologics and personalized medicine has created a demand for specialized excipients capable of stabilizing complex molecules and enabling targeted drug delivery. Roquette’s launch of Lycagel Flex, a hydroxypropyl pemix for nutraceutical and pharmaceutical softgel capsules, exemplifies this trend. Built on Roquette’s market-first Lycagel pea starch technology, this plant-based alternative to gelatin offers manufacturers the flexibility to customize formulations for a range of production and end-user needs. The innovative pea starch foundation also underscores the industry’s move towards sustainable bio-based excipients. The trend towards patient-centric drug development has also influenced excipient innovation. Excipients that can improve palatability, ease of swallowing, or enable novel dosage forms (such as orally disintegrating tablets) are in high demand. For example, IFF brought a super disintegrant Ac-Di-Sol, that supports faster disintegration and drug dissolution in oral disintegrating tablets, improving patient experience.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Our view The heightened regulatory scrutiny on excipients due to product contamination incidents has created a high risk perception and uncertainty around the regulatory acceptance of novel excipients. That said, novel excipients are central to the development of new drug modalities and therapies. Going forward, sustainability will also become an increasingly important factor in excipient selection and development. As the industry innovates towards biologics, personalized therapies, and patient-centric formulations, the role of high-quality, multifunctional excipients will only grow more vital in ensuring drug stability, bioavailability, and patient compliance. Companies that can navigate the complex regulatory landscape, invest in R&D, and offer high-quality, multifunctional excipients will be well-positioned to succeed in this evolving market.   
        subscribeSubscribe
        ExcelExcel Download

        Impressions: 3667

        https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-seqens-evonik-make-strategic-moves-new-guidelines-deal-with-contamination

        #PharmaFlow by PHARMACOMPASS
        12 Sep 2024
        Share Share

        MARKET PLACE

        Do you need sourcing support? Ask us

        REF. STANDARDS & IMPURITIES

        Upload your portfolio for free, ask us
        Ask Us for Pharmaceutical Supplier and Partner
        Ask Us, Find A Supplier / Partner
        No Commissions, No Strings Attached, Get Connected for FREE

        What are you looking for?

        How can we help you?

        The request can't be empty

        Please read our Privacy Policy carefully

        You must agree to the privacy policy

        The name can't be empty
        The company can't be empty.
        The email can't be empty Please enter a valid email.
        The mobile can't be empty
        • Privacy policy
        • Terms and conditions
        • Disclaimers
        • LinkedIn
        • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

        Market Place

        Market Place

        PharmaCompass

        Home

        Market Place

        Menu

        Post Enquiry

        Post Enquiry

        Market Place

        Market Place

        Search